Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply

Vince B. C. Biemans; Frank Hoentjen; Marieke J. Pierik

doi:10.1111/apt.16062

Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply

Vince B. C. Biemans^*, Frank Hoentjen, Marieke J. Pierik

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1255-1256
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	52
Issue number	7
DOIs	https://doi.org/10.1111/apt.16062
Publication status	Published - Oct 2020

Access to Document

10.1111/apt.16062

Cite this

@article{927bab3fceda4425b397048d9a4c9915,

title = "Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply",

author = "Biemans, {Vince B. C.} and Frank Hoentjen and Pierik, {Marieke J.}",

year = "2020",

month = oct,

doi = "10.1111/apt.16062",

language = "English",

volume = "52",

pages = "1255--1256",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "7",

}

Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply. / Biemans, Vince B. C.; Hoentjen, Frank; Pierik, Marieke J.
In: Alimentary Pharmacology & Therapeutics, Vol. 52, No. 7, 10.2020, p. 1255-1256.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Letter

T2 - effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply

AU - Biemans, Vince B. C.

AU - Hoentjen, Frank

AU - Pierik, Marieke J.

PY - 2020/10

Y1 - 2020/10

U2 - 10.1111/apt.16062

DO - 10.1111/apt.16062

M3 - Comment/Letter to the editor

C2 - 33016547

SN - 0269-2813

VL - 52

SP - 1255

EP - 1256

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 7

ER -